Sarah Podwika

  • Danville, PA
  • Gynecologic oncologist
NPI1285168203PAC ID3173893823
Part D claims, 2024
68
Publications
6
MIPS score, 2024
95
Hospital affiliations
4
Industry payments
$94
Practice address
100 North Academy Avenue, Danville, PA 17822
Practice phone
Call (570) 271-6211
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Geisinger Medical Center

Hospital · Danville, Pennsylvania

See all 6 affiliations

Find Sarah Podwika's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Sarah Podwika is a gynecologic oncologist in Danville, Pennsylvania

Sarah Podwika practices at Geisinger Medical Center in Danville, Pennsylvania, part of Risant Health.

Sarah Podwika's NPI, 1285168203, was assigned on April 17, 2017. Sarah Podwika holds Pennsylvania license MD486422.

NPI and contact details
Medicare PAC ID
3173893823
NPI enumeration date
April 17, 2017
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(570) 271-6211
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
35
Medical school graduation
2017

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Sarah Podwika practices at Geisinger Medical Center in Danville, Pennsylvania

Sarah Podwika's primary practice is Geisinger Medical Center, at 100 North Academy Avenue, Danville, PA 17822 in Montour County. The practice phone is (570) 271-6211.

Source: Dmand AI Affiliation Data

Sarah Podwika is affiliated with 4 sites of care and 2 medical groups

Sarah Podwika's primary practice is Geisinger Medical Center in Danville, Pennsylvania, part of Risant Health. Sarah Podwika is also affiliated with Geisinger Wyoming Valley Medical Center. The medical group on file is Geisinger. Dmand AI also links Sarah Podwika to 2 more hospitals and 1 medical group, each named with a free account.

See all 6 affiliations for Sarah Podwika

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Sarah Podwika's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Sarah Podwika practices, 4 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Geisinger Medical CenterAvailable with a free account
+3 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Sarah Podwika practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Risant Health and 6.2K+ hospitals, with verified contacts in the same login.

Sarah Podwika is one of 81 gynecologic oncologists in Pennsylvania

Gynecologic oncology is Sarah Podwika's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Sarah Podwika is licensed in Pennsylvania.

Specialties and state licenses

  • Gynecologic oncology, PennsylvaniaPrimaryLicense MD486422 · taxonomy 207VX0201X

Gynecologic oncologists near Sarah Podwika

Counts of gynecologic oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Sarah Podwika's patients have a median age of 68

Across all payers, Dmand AI patient panel data puts Sarah Podwika's median patient age at 68, with 99% women.

Sarah Podwika's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 68

Patient panel by sex, all payers

  • Women99%
  • Men0%

Source: Dmand AI Patient Panel Data

Sarah Podwika wrote 68 Medicare Part D claims in 2024

In 2024, Sarah Podwika wrote 68 Medicare Part D claims for 34 patients. 91% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $69 in total drug cost. In 2020, CMS named 30 claims across 2 drugs.

Part D claims, 202468
Drugs named by CMS1
Total drug cost$69
Part D patients34

Sarah Podwika's Part D claims by kind of drug, 2024

  • Generic62 claims91%
  • Brand-name and other6 claims9%

Sarah Podwika's most prescribed drugs by claims, 2021

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2020 to 2021

  • 2020
  • 2021
Claims for drugs CMS names
2020: 302021: 1357%

Drugs named by CMS: 1 in 2021, 2 in 2020.

See all prescribing by Sarah Podwika

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Sarah Podwika scored 95 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Sarah Podwika for performance year 2024, reported through an alternative payment model (APM). Sarah Podwika accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Sarah Podwika as offering telehealth. CMS counts 23 procedures of removal of the uterus by Sarah Podwika, more than 94% of the clinicians it reports for that procedure.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Sarah Podwika's MIPS scores, performance year 2024

  • 95of 100Final score
  • 83.5of 100Quality
  • 95of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Where Sarah Podwika ranks in Medicare procedure volume

Removal of the uterus
94th percentile23 procedures

CMS ranks each clinician against every clinician it reports for the same procedure category.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Sources: Doctors and Clinicians National Downloadable File (CMS); Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026; and Doctors and Clinicians Utilization Data (CMS)

For MedTech and pharma teams

Find gynecologic oncologists like Sarah Podwika by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Sarah Podwika has 6 publications on record

Dmand AI links 6 papers to Sarah Podwika, published from 2019 to 2025. Sarah Podwika has published most often in Gynecol Oncol Rep. Sarah Podwika's most frequent co-authors are Linda R. Duska, MD, Sarah H. Erickson, MD and Paola A. Gehrig, MD.

Papers6
Years published2019 to 2025

Sarah Podwika's papers by year, 2019 to 2025

Sarah Podwika's most frequent co-authors

Recent publications by Sarah Podwika

See all 6 publications and co-authors

See who Sarah Podwika researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Sarah Podwika works with, so you can find a warm path to the right gynecologic oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Sarah Podwika received $94 in industry payments from 2023 to 2025

CMS Open Payments shows 2 general payments to Sarah Podwika from 2 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $49.

General payments to Sarah Podwika by program year, 2023 to 2025

Companies that paid Sarah Podwika the most, 2023 to 2025

Share is of all general payments to this clinician.

See all payments to Sarah Podwika

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Sources for Sarah Podwika's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)Doctors and Clinicians Utilization Data (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Sarah Podwika

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Sarah Podwika's NPI number?

Sarah Podwika's NPI number is 1285168203. It was assigned on April 17, 2017, and it is active in the NPI Registry.

What does Sarah Podwika specialize in?

Sarah Podwika is a gynecologic oncologist in Danville, Pennsylvania. The primary specialty in the NPI Registry is Gynecologic Oncology Physician (taxonomy code 207VX0201X).

Where does Sarah Podwika practice?

Sarah Podwika practices at 100 North Academy Avenue, Danville, PA 17822. Sarah Podwika's primary practice is Geisinger Medical Center in Danville, Pennsylvania, part of Risant Health. Dmand AI also links Sarah Podwika to 2 hospitals and 1 medical group.

What is Sarah Podwika's office phone number?

The practice phone on file for Sarah Podwika is (570) 271-6211.

What is Sarah Podwika's medical license number?

Sarah Podwika holds Pennsylvania license MD486422.

Which hospitals is Sarah Podwika affiliated with?

Sarah Podwika practices at Geisinger Medical Center in Danville, Pennsylvania. Sarah Podwika is also affiliated with Geisinger Wyoming Valley Medical Center. Dmand AI links Sarah Podwika to 2 more hospitals.

What medical group is Sarah Podwika part of?

Sarah Podwika is linked to Geisinger. Dmand AI links Sarah Podwika to 1 more medical group.

Does Sarah Podwika accept Medicare?

Yes. CMS lists Sarah Podwika as accepting Medicare assignment.

Does Sarah Podwika offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Sarah Podwika as offering telehealth services.

What is Sarah Podwika's MIPS score?

Sarah Podwika's MIPS final score for performance year 2024 is 95 out of 100, reported through an alternative payment model (APM).

Show 5 more questionsShow fewer questions

What drugs does Sarah Podwika prescribe most?

In 2021 Medicare Part D data, Sarah Podwika's most prescribed drugs by claims were Oxycodone HCl.

Has Sarah Podwika received payments from drug or device companies?

CMS Open Payments shows $94 in general payments to Sarah Podwika from 2 companies from 2023 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.

How long has Sarah Podwika been practicing?

Sarah Podwika graduated from medical school in 2017, 9 years ago.

Does Sarah Podwika do research?

Dmand AI links 6 publications to Sarah Podwika, published from 2019 to 2025.

Who does Sarah Podwika publish with?

Sarah Podwika's most frequent co-authors are Linda R. Duska, MD (2 shared papers), Sarah H. Erickson, MD (1 shared paper) and Paola A. Gehrig, MD (1 shared paper).

Selling to gynecologic oncology practices?

See gynecologic oncologists in Pennsylvania by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)